157 related articles for article (PubMed ID: 35372371)
21. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
[TBL] [Abstract][Full Text] [Related]
22. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the Hematopoietic Stem Cell Donor Pool as a Source of HLA-Homozygous Induced Pluripotent Stem Cells for Haplobanking: Combined Analysis of the Cord Blood Inventory and Bone Marrow Donor Registry.
Shin S; Song EY; Kwon YW; Oh S; Park H; Kim NH; Roh EY
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e202-e208. PubMed ID: 32439474
[TBL] [Abstract][Full Text] [Related]
24. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
25. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
26. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.
Macarthur CC; Fontes A; Ravinder N; Kuninger D; Kaur J; Bailey M; Taliana A; Vemuri MC; Lieu PT
Stem Cells Int; 2012; 2012():564612. PubMed ID: 22550511
[TBL] [Abstract][Full Text] [Related]
27. Can cord blood banks transform into induced pluripotent stem cell banks?
Zhou H; Rao MS
Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
[TBL] [Abstract][Full Text] [Related]
28. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
Kögler G; Somville T; Göbel U; Hakenberg P; Knipper A; Fischer J; Adams O; Krempe C; McKenzie C; Rüttgers H; Meier W; Bellmann O; Streng H; Ring A; Rosseck U; Rocha V; Wernet P
Klin Padiatr; 1999; 211(4):224-32. PubMed ID: 10472555
[TBL] [Abstract][Full Text] [Related]
29. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
[TBL] [Abstract][Full Text] [Related]
30. Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.
Park TS; Bhutto I; Zimmerlin L; Huo JS; Nagaria P; Miller D; Rufaihah AJ; Talbot C; Aguilar J; Grebe R; Merges C; Reijo-Pera R; Feldman RA; Rassool F; Cooke J; Lutty G; Zambidis ET
Circulation; 2014 Jan; 129(3):359-72. PubMed ID: 24163065
[TBL] [Abstract][Full Text] [Related]
31. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population.
Yoshida S; Kato TM; Sato Y; Umekage M; Ichisaka T; Tsukahara M; Takasu N; Yamanaka S
Med; 2023 Jan; 4(1):51-66.e10. PubMed ID: 36395757
[TBL] [Abstract][Full Text] [Related]
32. cGMP Generation of Human Induced Pluripotent Stem Cells with Messenger RNA.
Ni Y; Zhao Y; Warren L; Higginbotham J; Wang J
Curr Protoc Stem Cell Biol; 2016 Nov; 39(1):4A.6.1-4A.6.25. PubMed ID: 31816187
[TBL] [Abstract][Full Text] [Related]
33. Umbilical Cord Tissue as a Source of Young Cells for the Derivation of Induced Pluripotent Stem Cells Using Non-Integrating Episomal Vectors and Feeder-Free Conditions.
Mohamed A; Chow T; Whiteley J; Fantin A; Sorra K; Hicks R; Rogers IM
Cells; 2020 Dec; 10(1):. PubMed ID: 33396312
[TBL] [Abstract][Full Text] [Related]
34. [Present and Future of an iPS Cell Stock for Regenerative Medicine].
Hanatani T; Takasu N
Rinsho Byori; 2017 Feb; 65(2):160-166. PubMed ID: 30762982
[TBL] [Abstract][Full Text] [Related]
35. Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.
Tannenbaum SE; Turetsky TT; Singer O; Aizenman E; Kirshberg S; Ilouz N; Gil Y; Berman-Zaken Y; Perlman TS; Geva N; Levy O; Arbell D; Simon A; Ben-Meir A; Shufaro Y; Laufer N; Reubinoff BE
PLoS One; 2012; 7(6):e35325. PubMed ID: 22745653
[TBL] [Abstract][Full Text] [Related]
36. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
Hu K; Yu J; Suknuntha K; Tian S; Montgomery K; Choi KD; Stewart R; Thomson JA; Slukvin II
Blood; 2011 Apr; 117(14):e109-19. PubMed ID: 21296996
[TBL] [Abstract][Full Text] [Related]
37. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders.
Sun J; Allison J; McLaughlin C; Sledge L; Waters-Pick B; Wease S; Kurtzberg J
Transfusion; 2010 Sep; 50(9):1980-7. PubMed ID: 20546200
[TBL] [Abstract][Full Text] [Related]
38. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
39. Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.
Shafa M; Yang F; Fellner T; Rao MS; Baghbaderani BA
Front Med (Lausanne); 2018; 5():69. PubMed ID: 29600249
[TBL] [Abstract][Full Text] [Related]
40. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
